跳至主要内容
临床试验/ACTRN12606000156583
ACTRN12606000156583已完成3 期

Oral misoprostol versus vaginal prostaglandin E2 for the induction of labour at term (beyond 37 weeks gestation).

The Department of Obstetrics & Gynaecology, The University of Adelaide0 个研究点目标入组 738 人开始时间: 2001年6月3日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
738

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
Female

入选标准

  • Singleton pregnancy, at a gestational age of 37 weeks or more, planned induction of labour for defined obstetric and medical conditions - prolonged pregnancy, pre-eclampsia, hypertensive disoreders, antepartum haemorrhage (ecluding placenta praevia), oligohydramnios, IUGR, or abnormal glucose tolerance.

排除标准

  • Induction planned for non-defined conditions, active labour o, or a favourable cervix, contraindication to vaginal birth, previous uterine surgery, ruptured membranes, parity 5 or more, history of asthma, glaucoma or heart disease, suspected cephalo-pelvic disproportion, abnormal lie, breech presentation, fetal distress/non-reassuring fetal heart trace, multiple pregnancy, intrauterine infection, vasa praevia, placenta praevia, active herpes infection, maternal illness precluding induction of labour, and maternal renal or hepatic failure.

研究者

发起方
The Department of Obstetrics & Gynaecology, The University of Adelaide

相似试验